Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ryohei, Kaseda"'
Autor:
Satoshi Shoji, Michihiro Hosojima, Hideyuki Kabasawa, Rie Kondo, Satoru Miura, Satoshi Watanabe, Nobumasa Aoki, Ryohei Kaseda, Shoji Kuwahara, Naohito Tanabe, Yoshiaki Hirayama, Ichiei Narita, Toshiaki Kikuchi, Hiroshi Kagamu, Akihiko Saito
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Cisplatin is a potent chemotherapeutic agent used to treat a variety of solid tumors. One of the major side effects of cisplatin is dose-limiting nephrotoxicity. We recently demonstrated that the renal uptake of cisplatin and resu
Externí odkaz:
https://doaj.org/article/b34007b93cf94745b01a47c2ddf10744
Autor:
Koji Toba, Michihiro Hosojima, Hideyuki Kabasawa, Shoji Kuwahara, Toshiko Murayama, Keiko Yamamoto-Kabasawa, Ryohei Kaseda, Eri Wada, Reiko Watanabe, Naohito Tanabe, Yoshiki Suzuki, Ichiei Narita, Akihiko Saito
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Dietary acid load has been suggested to mediate the progression of chronic kidney disease (CKD). However, it is unclear what kinds of foods are actually associated with dietary acid load in patients with CKD. The self-administered
Externí odkaz:
https://doaj.org/article/e7a33f697590417cb0859a826927ba02
Autor:
Yusuke Nakagawa, Ryohei Kaseda, Yuya Suzuki, Hirofumi Watanabe, Tadashi Otsuka, Suguru Yamamoto, Yoshikatsu Kaneko, Shin Goto, Yasuhiko Terada, Tomoyuki Haishi, Susumu Sasaki, Ichiei Narita
Publikováno v:
Kidney360. 4:582-590
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::946b48e6e4387c4cc388a2a0dc80775c
https://doi.org/10.34067/kid.0000000000000072
https://doi.org/10.34067/kid.0000000000000072
Autor:
Yuya Suzuki, Tadashi Otsuka, Yuki Yoshioka, Tomomichi Iida, Shingo Maruyama, Hirofumi Watanabe, Ryohei Kaseda, Suguru Yamamoto, Yoshikatsu Kaneko, Shin Goto, Ryuji Aoyagi, Ichiei Narita
Publikováno v:
Clinical and Experimental Nephrology. 27:565-573
Background The post-dialysis plasma level of human atrial natriuretic peptide (hANP) reflects the fluid volume in patients on hemodialysis. The threshold hANP level is reportedly 100 pg/mL; however, the clinical usefulness of the threshold hANP level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4a4c5d08a1884b9c0e1dfe4f528bc74
https://doi.org/10.1007/s10157-023-02333-1
https://doi.org/10.1007/s10157-023-02333-1
Autor:
Ryohei Kaseda, Yohei Tsuchida, Hai-Chun Yang, Patricia G. Yancey, Jianyong Zhong, Huan Tao, Aihua Bian, Agnes B. Fogo, Mac Rae F. Linton, Sergio Fazio, Talat Alp Ikizler, Valentina Kon
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Our aim was to evaluate lipid trafficking and inflammatory response of macrophages exposed to lipoproteins from subjects with moderate to severe chronic kidney disease (CKD), and to investigate the potential benefits of activating
Externí odkaz:
https://doaj.org/article/874bf4c1e1614a4f83c19bb9c7bed1a0
Autor:
Michihiro Hosojima, Hideyuki Kabasawa, Ryohei Kaseda, Tomomi Ishikawa-Tanaka, Yoshitsugu Obi, Toshiko Murayama, Shoji Kuwahara, Yoshiki Suzuki, Ichiei Narita, Akihiko Saito
Publikováno v:
Kidney360
BACKGROUND: The benefits of dietary protein restriction in CKD remain unclear, largely due to inadequate adherence in most clinical trials. We examined whether low-protein rice (LPR) previously developed to reduce the protein content of rice, a major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe0197469b191cf0bac969db61cd7a78
https://doi.org/10.34067/kid.0002982022
https://doi.org/10.34067/kid.0002982022
Publikováno v:
The Journal of Clinical Pharmacology. 62:1419-1425
The number of fractures related to osteoporosis is expected to increase. Therefore, clarifying the risk of acute kidney injury (AKI) associated with each type of antiosteoporotic drug may avoid discontinuation of osteoporosis pharmacotherapy due to o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8580a8d3601862d691d56f088dcd648
https://doi.org/10.1002/jcph.2091
https://doi.org/10.1002/jcph.2091
Autor:
Sawako Goto, Yutaka Yoshida, Michihiro Hosojima, Shoji Kuwahara, Hideyuki Kabasawa, Hiroyuki Aoki, Tomomichi Iida, Ryuhei Sawada, Daisuke Ugamura, Yuta Yoshizawa, Kazuya Takemoto, Koichi Komochi, Ryota Kobayashi, Ryohei Kaseda, Eishin Yaoita, Satoru Nagatoishi, Ichiei Narita, Kouhei Tsumoto, Akihiko Saito
Publikováno v:
Journal of Hypertension; Nov2023, Vol. 41 Issue 11, p1831-1843, 13p
Publikováno v:
The Journal of Clinical Pharmacology. 62:631-635
The association between the use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors and the occurrence of drug-induced kidney injury has not been evaluated. This study assessed whether the use of SGLT-2 inhibitors decreases the risk of drug-induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3ded848806eb6d30e5c048adb1a037
https://doi.org/10.1002/jcph.1998
https://doi.org/10.1002/jcph.1998
Autor:
Hiroyuki Aoki, Shoji Kuwahara, Hideyuki Kabasawa, Michihiro Hosojima, Ryohei Kaseda, Ichiei Narita, Akihiko Saito, Valentina Kon, Yuki Higuchi
Publikováno v:
J Am Nutr Assoc
BACKGROUND: Chronic kidney disease (CKD) impairs the anti-inflammatory effects of high-density lipoprotein (HDL) and increases cardiovascular mortality. Though the potential role of dietary interventions to manage HDL is well studied, the clinical tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0e1fa7b20956a71939b2ee0749677b
https://doi.org/10.1080/07315724.2021.1950584
https://doi.org/10.1080/07315724.2021.1950584